Evidence map›Paper›PMID 30997632›Full record

ArticleTropical animal health and production2019

Suspected resistance of Trypanosoma species to diminazene aceturate on a cattle farm in Nigeria.

Paul Olalekan Odeniran, Ewan Thomas Macleod, Isaiah Oluwafemi Ademola, Susan Christina Welburn

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Tropical animal health and production, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Knowledge mapping of risk mitigation measures against vector-borne diseases.EFSA journal. European Food Safety Authority · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Paul Olalekan OdeniranDepartment of Veterinary Parasitology and Entomology, Faculty of Veterinary Medicine, University of Ibadan, Nigeria, Ibadan, Nigeria. drpaulekode@gmail.com.
Ewan Thomas MacleodDivision of Infection and Pathway Medicine, University of Edinburgh, Edinburgh, EH8 9YL, UK.
Isaiah Oluwafemi AdemolaDepartment of Veterinary Parasitology and Entomology, Faculty of Veterinary Medicine, University of Ibadan, Nigeria, Ibadan, Nigeria.
Susan Christina WelburnDivision of Infection and Pathway Medicine, University of Edinburgh, Edinburgh, EH8 9YL, UK.
University of Edinburgh · GBUniversity of Ibadan · NG

Funding

Commonwealth Scholarship Commission NGCN-2016-196
6 · The paper itself

Abstract

African animal trypanosomiasis is a major cause of mortality and economic losses for the livestock industry in Nigeria. Chemotherapy has been the most reliable option for cattle herders, and the most commonly found drug on the market is diminazene aceturate. To ascertain the long-term efficacy of this compound, we sampled a cattle herd in Ogun State, Nigeria, 2 months after they were treated with diminazene aceturate. The ITS-PCR results revealed 19 positives for trypanosome DNA out of the 79 samples tested (24.1%, 95% CI 16.0-34.5). Seventeen out of the total 19 positives were Trypanosoma congolense (21.5%, 95% CI 13.9-31.8). Mixed infections were also observed. Therefore, the persistence of bovine trypanosomiasis at this Nigerian cattle farm despite treatment could be due to diminazene aceturate resistant trypanosomes being present in the herd.

Indexed as

AnimalsCattleCattle DiseasesDiminazeneDNA, IntergenicDrug ResistanceFarmsNigeriaPolymerase Chain ReactionTrypanocidal AgentsTrypanosoma congolenseTrypanosomiasis, AfricanTrypanosomiasis, BovineDiminazenediminazene aceturateDNA, IntergenicTrypanocidal AgentsDiminazene aceturateNigeriaTrypanosoma congolense

Identifiers

PMID30997632
OpenAlexW2939976672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.